Jinmin Miao

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity”.

Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity

Angewandte Chemie International Edition(2025)10.1002/anie.202525126

N/A

0.112DataRank · unranked

1 citations

Frederick Nguele Meke, Zheng Zhang, Zhong‐Yin Zhang, Aaron D. Krabill, Christine S. Muli +12 more

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Neuron(2022)10.1016/j.neuron.2022.10.028

N/A

0DataRank · unranked

79 citations

Chao Yang, Xuejie Wang, Jinmin Miao, Weitao Chen, Yiren Zhou +13 more

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Blood(2022)10.1182/blood.2022016580

N/A

0DataRank · unranked

16 citations

Yunpeng Bai, Michihiro Kobayashi, Shiyu Xiao, Wenjie Cai, Sergio Barajas +21 more

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Angewandte Chemie International Edition(2023)10.1002/anie.202303818

N/A

0DataRank · unranked

56 citations

Jinmin Miao, Yiming Miao, Zihan Qu, Sheng Zhang, Peipei Zhu +10 more

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Chemical Science(2023)10.1039/d3sc04541b

N/A

0DataRank · unranked

17 citations

Jiajun Dong, Yiming Miao, Yunpeng Bai, Zihan Qu, Brenson A. Jassim +8 more

PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0115

N/A

0DataRank · unranked

5 citations

Yunpeng Bai, Michihiro Kobayashi, Shiyu Xiao, Sergio Barajas, Wenjie Cai +25 more

Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53 -deficient Sarcoma and Lymphoma Mouse Models

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0308

N/A

0DataRank · unranked

5 citations

Yunpeng Bai, Diego Ruiz-Avila, Colin Carlock, Jinan Ayub, Jinmin Miao +4 more

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Angewandte Chemie(2023)10.1002/ange.202303818

N/A

0DataRank · unranked

1 citations

Jinmin Miao, Yiming Miao, Zihan Qu, Sheng Zhang, Peipei Zhu +10 more

Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers

Journal of Clinical Investigation(2024)10.1172/jci177142

N/A

0DataRank · unranked

14 citations

Yunpeng Bai, Jinmin Miao, Allison A. Murray, Jianping Lin, Jiajun Dong +8 more

Discovery and evaluation of novel SHIP-1 inhibitors

Bioorganic & Medicinal Chemistry(2024)10.1016/j.bmc.2024.117965

N/A

0DataRank · unranked

7 citations

Jianping Lin, Jiajun Dong, Ovini Amarasinghe, Emily R. Mason, Shaoyou Chu +5 more

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

ChemMedChem(2024)10.1002/cmdc.202300669

N/A

0DataRank · unranked

6 citations

Zhong-Yin Zhang, Jinmin Miao

Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy

European Journal of Medicinal Chemistry(2024)10.1016/j.ejmech.2024.117129

N/A

0DataRank · unranked

2 citations

Yunpeng Bai, Zihan Qu, C. Sander, Jianping Lin, Jinmin Miao +2 more

Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00149

N/A

0DataRank · unranked

4 citations

Brenson A. Jassim, Kedric L. Milholland, Zihan Qu, Yunpeng Bai, Yiming Miao +6 more

Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation

UNC Libraries(2024)10.17615/66tf-t772

N/A

0DataRank · unranked

0 citations

Mitsuhiko Ikura, Ivette Valencia-Sama, Benjamin Grant, Ming-Sound Tsao, Jonathan St‐Germain +14 more

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.24.684367

N/A

0DataRank · unranked

0 citations

Marc‐Damien Lourenco‐Rodrigues, Luc J. I. Zimmermann, Marion Pugliano, Cécile Loubière, Fabienne Proamer +8 more

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

Nature Communications(2021)10.1038/s41467-021-26526-y

N/A

0DataRank · unranked

46 citations

Yoshihito Kano, Jonathan St‐Germain, Nikolina Radulovich, Molly L. Udaskin, Ahmet Mentes +17 more

Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity

Angewandte Chemie(2025)10.1002/ange.202525126

N/A

0DataRank · unranked

0 citations

Frederick Nguele Meke, Zheng Zhang, Aaron D. Krabill, Christine S. Muli, Brenson A. Jassim +12 more